Axcelis Technologies, Inc.

  • Market Cap: Small Cap
  • Industry: Industrial Manufacturing
  • ISIN: US0545402085
USD
89.10
6.67 (8.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Axcelis Technologies, Inc. stock-summary
stock-summary
Axcelis Technologies, Inc.
Industrial Manufacturing
Axcelis Technologies, Inc. designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. The Company offers a complete line of high energy, high current and medium current implanters for all application requirements. The Company's Purion XE high energy system combines its radio frequency (RF) Linac high energy, spot beam technology with the Purion platform. The Company also offers the Purion M medium current system. The Company's Purion M systems also offer differentiation for specialty applications, such as hot silicon carbide. The Company's Purion H high current system is extendable into ultra-low energy applications to satisfy future process requirements, including leakage current performance.
Company Coordinates stock-summary
Company Details
108 Cherry Hill Dr , BEVERLY MA : 01915-1066
stock-summary
Tel: 1 978 78740001 978 7874000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 128 Schemes (60.82%)

Foreign Institutions

Held by 176 Foreign Institutions (15.78%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Richard Faubert
Independent Chairman of the Board
Ms. Mary Puma
President, Chief Executive Officer, Director
Dr. Tzu-Yin Chiu
Independent Director
Mr. R. John Fletcher
Independent Director
Mr. Arthur George
Independent Director
Mr. Joseph Keithley
Independent Director
Mr. John Kurtzweil
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
195 Million
(Quarterly Results - Jun 2025)
Net Profit:
31 Million
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 2,571 Million (Small Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

15.51%

stock-summary
Price to Book

2.51